We came across a bullish thesis on ResMed Inc. on CompoundingLab’s Substack. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.'s share was trading at $273.01 as of October 13th. RMD’s trailing and forward P/E were 29.09 and 25.91 respectively according to Yahoo Finance.
[caption id="attachment_568520" align="aligncenter" width="750"]ResMed (RMD) has quietly established itself as one of the most durable medtech franchises over the past five years, yet its stock has lagged the S&P 500. This underperformance...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.